CircATG4B-222aa directly binds to TMED10, preventing TMED10 interaction with ATG4B, thus increasing autophagy, which triggers oxaliplatin resistance, thereby reducing the chemosensitivity of CRC cells (Fig. 5a) 56. Here, TMED10 is linked to colorectal carcinoma.